Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — Center for Drug Evaluation and Research

Tracked across 8 events · 52 articles · First seen Jun 12, 2026 · Last active Sep 02, 2026

Sentiment
10
Attention
4
Events
8
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
Impact: The CDE is the specific agency that granted the BTD, playing a key role in the regulatory process. Its decision is crucial for the accelerated development of the combination therapy.
Aug 03, 2026 · 6 articles
4 10
Regulatory
Impact: FDA center responsible for reviewing and approving the therapy; its officials commented on the approval.
Aug 20, 2026 · 6 articles
4 0
Business
Impact: The United States — Center for Drug Evaluation and Research provided positive pre-submission regulatory feedback for NCX 470, which is crucial for the drug's approval process in China.
Jun 18, 2026 · 7 articles
4 60
Regulatory
Impact: CBER, the FDA center responsible for the review, granted the supplemental approval and utilized expedited review programs.
Jul 01, 2026 · 6 articles
4 10
Business
Impact: China's CDE granted Breakthrough Therapy Designation and is reviewing the first-line application, supporting Sunvozertinib's availability in China.
Sep 01, 2026 · 6 articles
4 0
Business
Impact: The United States — Center for Drug Evaluation and Research accepted a supplemental New Drug Application for Gumokimab in active ankylosing spondylitis, indicating potential future market expansion for the drug.
Jun 12, 2026 · 7 articles
3 0
Tech
Impact: The CDE, as part of NMPA, approved the IND application, playing a regulatory role in the event.
Jul 27, 2026 · 6 articles
4 0
Business
Impact: China's CDE received sNDA for first-line Zegfrovy and granted Breakthrough Therapy Designation.
Jul 14, 2026 · 8 articles
United States — Food and Drug Administration ↔ United States — Center for Drug Evaluation and Research
United States — Food and Drug Administration ↔ United States — Center for Drug Evaluation and Research
ERGEN INTELLIGENCE
Track United States — Center for Drug Evaluation and Research live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.